REPLIGEN CORP (RGEN) Forecast, Price Target & Analyst Ratings

NASDAQ:RGEN • US7599161095

125.84 USD
+2.78 (+2.26%)
At close: Mar 4, 2026
125.84 USD
0 (0%)
After Hours: 3/4/2026, 5:53:28 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REPLIGEN CORP (RGEN).

Forecast Snapshot

Consensus Price Target

Price Target
$191.52
+ 52.19% Upside

Next Earnings Forecast

Earnings Estimate
Release DateApr 27, 2026
PeriodQ1 / 2026
EPS Estimate$0.38
Revenue Estimate195.75M

ChartMill Buy Consensus

Rating
81.43%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$191.52
Upside
+ 52.19%
From current price of $125.84 to mean target of $191.52, Based on 28 analyst forecasts
Low
$161.60
Median
$193.80
High
$214.20

Price Target Revisions

1 Month
-1.21%
3 Months
0.18%

Price Target Summary

28 analysts have analysed RGEN and the average price target is 191.52 USD. This implies a price increase of 52.19% is expected in the next year compared to the current price of 125.84.
The average price target has been revised upward by 0.18% in the past 3 months.
 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RGEN Current Analyst RatingRGEN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

RGEN Historical Analyst RatingsRGEN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
81.43%
RGEN was analyzed by 28 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about RGEN.
In the previous month the buy percentage consensus was at a similar level.
RGEN was analyzed by 28 analysts, which is quite many. So the average rating should be quite meaningful.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-25UBSMaintains Buy -> Buy
2026-02-25BarclaysMaintains Overweight -> Overweight
2026-02-25Wells FargoMaintains Overweight -> Overweight
2026-02-25Evercore ISI GroupMaintains Outperform -> Outperform
2026-01-16UBSMaintains Buy -> Buy
2025-12-15BarclaysMaintains Overweight -> Overweight
2025-12-15Wells FargoMaintains Overweight -> Overweight
2025-10-29BarclaysMaintains Overweight -> Overweight
2025-10-29Canaccord GenuityMaintains Hold -> Hold
2025-10-07Evercore ISI GroupMaintains Outperform -> Outperform
2025-10-02BarclaysMaintains Overweight -> Overweight
2025-10-01HSBCInitiate Buy
2025-09-22Evercore ISI GroupUpgrade In-Line -> Outperform
2025-09-12JefferiesMaintains Hold -> Hold
2025-09-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-30RBC CapitalMaintains Outperform -> Outperform
2025-07-30Wells FargoMaintains Overweight -> Overweight
2025-07-08Evercore ISI GroupMaintains In-Line -> In-Line
2025-06-24BarclaysInitiate Overweight
2025-05-05HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-30RBC CapitalMaintains Outperform -> Outperform
2025-04-29JP MorganMaintains Overweight -> Overweight
2025-04-17Canaccord GenuityMaintains Hold -> Hold
2025-04-16Canaccord GenuityMaintains Hold -> Hold
2025-03-18Evercore ISI GroupInitiate In-Line

Next Earnings Forecast Details

Next Earnings Details

Release DateApr 27, 2026
PeriodQ1 / 2026
EPS Estimate$0.38
Revenue Estimate195.75M
Revenue Q2Q15.71%
EPS Q2Q-1.89%
Number of Analysts22

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.10%
EPS (1 Month)
0.13%
EPS (3 Months)
0.05%

Next Earnings Summary

RGEN is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is 0.38 USD and the consensus revenue estimate is 195.75M USD.
The next earnings revenue estimate has been revised upward by 0.1% in the past 3 months.
 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RGEN revenue by date.RGEN revenue by date.
632.362M
-21.10%		634.439M
0.33%		738.256M
16.36%		842.45M
14.11%		966.39M
14.71%		1.116B
15.48%		1.306B
17.03%		1.541B
17.99%		1.914B
24.21%		2.382B
24.45%		2.943B
23.55%
EBITDA
YoY % growth
RGEN ebitda by date.RGEN ebitda by date.
147.988M
-40.09%		81.728M
-44.77%		138.047M
68.91%		170.18M
23.28%		212.6M
24.93%		268.23M
26.17%		358.26M
33.56%		453.35M
26.54%		592.93M
30.79%		580.33M
-2.13%		688.52M
18.64%
EBIT
YoY % growth
RGEN ebit by date.RGEN ebit by date.
79.903M
-59.23%		12.055M
-84.91%		59.302M
391.93%		119.56M
101.61%		171.44M
43.39%		245.72M
43.33%		326.66M
32.94%		421.77M
29.12%		543.35M
28.83%		626.18M
15.24%		781.22M
24.76%
Operating Margin
RGEN operating margin by date.RGEN operating margin by date.
12.64%1.90%8.03%14.19%17.74%22.02%25.01%27.37%28.39%26.29%26.55%
EPS
YoY % growth
RGEN eps by date.RGEN eps by date.
1.73
-47.26%		1.48
-14.45%		1.71
15.54%		1.99
16.45%		2.49
25.25%		3.17
27.15%		4.32
36.25%		5.44
26.02%		6.85
25.89%		6.68
-2.53%		8.05
20.46%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.38
-1.89%		0.46
24.69%		0.54
17.54%		0.61
23.47%		0.65
70.61%		0.68
46.65%		0.74
36.46%		0.79
30.94%
Revenue
Q2Q % growth		195.75M
15.71%		207.06M
13.54%		212.35M
12.47%		223.24M
12.80%		226.66M
15.79%		238.53M
15.20%		242.02M
13.97%		249.97M
11.97%
EBITDA
Q2Q % growth		34.536M
26.71%		40.44M
-26.26%		43.768M
-42.12%		49.003M
-49.28%		49.995M
44.76%		51.133M
26.44%		55.452M
26.70%		59.425M
21.27%
EBIT
Q2Q % growth		22.402M
161.98%		28.059M
74.74%		30.947M
83.93%		37.027M
107.23%		40.29M
79.85%		41.432M
47.66%		45.808M
48.02%		49.781M
34.45%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RGEN Yearly Revenue VS EstimatesRGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B 2.5B
RGEN Yearly EPS VS EstimatesRGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.86%
EPS Next 5 Year
26.07%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
14.28%
Revenue Next 5 Year
15.56%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
41.89%
EBIT Next 5 Year
37.01%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

REPLIGEN CORP / RGEN Forecast FAQ

What do analysts expect the price target to be for REPLIGEN CORP (RGEN)?

28 analysts have analysed RGEN and the average price target is 191.52 USD. This implies a price increase of 52.19% is expected in the next year compared to the current price of 125.84.


What is the next earnings date for RGEN stock?

REPLIGEN CORP (RGEN) will report earnings on 2026-04-27, before the market open.


What are the consensus estimates for RGEN stock next earnings?

The consensus EPS estimate for the next earnings of REPLIGEN CORP (RGEN) is 0.38 USD and the consensus revenue estimate is 195.75M USD.


What is the expected long term growth rate for RGEN stock?

The expected long term growth rate for REPLIGEN CORP (RGEN) is 14.28%.